The Role of STAMP2 in Pathogenesis of Chronic Diseases Focusing on Nonalcoholic Fatty Liver Disease: A Review
Nonalcoholic fatty liver disease (NAFLD) is a major health issue. NAFLD can progress from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH). NASH can progress to cirrhosis or hepatocellular carcinoma. Unfortunately, there is no currently approved pharmacologic therapy for NAFLD patient...
Main Authors: | Hye Young Kim, Young Hyun Yoo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/9/2082 |
Similar Items
-
Six-Transmembrane Epithelial Antigen of Prostate 3 Promotes Hepatic Insulin Resistance and Steatosis
by: Ting Ding, et al.
Published: (2023-01-01) -
Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease
by: Meng Yang, et al.
Published: (2021-05-01) -
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
by: Shun Ishido, et al.
Published: (2023-06-01) -
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
by: Amedeo Lonardo, et al.
Published: (2022-11-01) -
Pharmacological potential of ginseng and ginsenosides in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Young-Su Yi
Published: (2024-03-01)